Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2018 / Cilt: 26 - Sayı: 4

Comparison of aortic cross-clamping versus beating heart surgery in tricuspid valve repair

Triküspid kapak tamirinde atan kalp ile aortik kros klemp cerrahinin karşılaştırılması

Pages
519–527
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Secondary endpoints were cross-clamp and cardiopulmonarybypass times, postoperative inotropic support, temporary pacemakerrequirement, and residual tricuspid regurgitation at discharge and atone year.Results: Overall hospital mortality was 7% (n=14) (cross-clamping 7% vs.beating heart 7%; p>0.05).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The aim of this study was to evaluate the clinicaloutcomes of tricuspid valve repair using aortic cross-clamping versususing beating heart surgery.Methods: A total of 208 patients (67 males, 141 females; mean age61.5±9.2 years; range, 29 to 81 years) who underwent concomitantcardiac surgery and tricuspid valve repair between January 2007 andJanuary 2016 at a single center were included.
📊
Key Findings & Data:Two surgical strategies fortricuspid valve repair with aortic cross-clamping (n=102) or on beatingheart (n=106) were compared.
💡
Conclusion & Impact:Secondary endpoints were cross-clamp and cardiopulmonarybypass times, postoperative inotropic support, temporary pacemakerrequirement, and residual tricuspid regurgitation at discharge and atone year.Results: Overall hospital mortality was 7% (n=14) (cross-clamping 7% vs.beating heart 7%; p>0.05).
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Background: The aim of this study was to evaluate the clinicaloutcomes of tricuspid valve repair using aortic cross-clamping versususing beating heart surgery.Methods: A total of 208 patients (67 males, 141 females; mean age61.5±9.2 years; range, 29 to 81 years) who underwent concomitantcardiac surgery and tricuspid valve repair between January 2007 andJanuary 2016 at a single center were included. Two surgical strategies fortricuspid valve repair with aortic cross-clamping (n=102) or on beatingheart (n=106) were compared. Primary endpoints were in-hospitalmortality and the rate of permanent pacemaker placement aftersurgery. Secondary endpoints were cross-clamp and cardiopulmonarybypass times, postoperative inotropic support, temporary pacemakerrequirement, and residual tricuspid regurgitation at discharge and atone year.Results: Overall hospital mortality was 7% (n=14) (cross-clamping 7% vs.beating heart 7%; p>0.05). The mean cross-clamp and cardiopulmonarybypass times were significantly longer in the aortic cross-clampinggroup (p=0.0001). Also, a higher number of patients in this groupneeded inotropic support (78/102) than the beating heart group (57/106)(p 2 tricuspid regurgitationwas more commonly seen in the cross-clamping group (16% vs. 3%,respectively; p=0.0023). At one year of follow-up, residual >2 tricuspidregurgitation was present in 22 patients (23%) in the aortic crossclampinggroup and in eight patients (8%) in the beating heart group(p=0.0048).Conclusion: Tricuspid valve repair on beating heart offers less inotropicsupport and a lower rate of postoperative permanent pacemakerplacement requirement and residual tricuspid regurgitation, althoughboth techniques yield similar postoperative clinical outcomes. Theseresults support the use of tricuspid valve repair on a beating heart inconcomitant left-sided valvular heart surgery.

Özet

Amaç: Bu çalışmada atan kalbe kıyasla aortik kros klemp sırasında triküspid kapak tamirinin klinik sonuçları değerlendirildi. Çalışma planı: Bu çalışmaya Ocak 2007 - Ocak 2016 tarihleri arasında tek bir merkezde eş zamanlı kalp ameliyatı ve triküspid kapak tamiri yapılan toplam 208 hasta (67 erkek, 141 kadın; ort. yaş: 61.5±9.2 yıl; dağılım, 29-81 yıl) alındı. Aortik kros klemp ile (n=102) veya atan kalpte (n=106) triküspid kapak tamirine yönelik iki cerrahi strateji karşılaştırıldı. Çalışmanın primer sonlanım noktaları hastane mortalitesi ve kalıcı pacemaker implantasyonu gereksinim oranı idi. Sekonder sonlanım noktaları ise, kros klemp ve kardiyopulmoner baypas süreleri, ameliyat sonrası inotrop desteği, geçici pacemaker gereksinimi ve taburculukta ve birinci yılda rezidüel triküspid yetmezliği idi. Bulgular: Genel hastane mortalitesi %7 (n=14) idi (kros klemp grubunda %7 ve atan kalpte %7; p>0.05). Ortalama kros klemp ve kardiyopulmoner baypas süreleri, aortik kros klemp grubunda anlamlı düzeyde daha uzundu (p=0.0001). Ayrıca, atan kalp grubuna kıyasla (57/106), bu grupta daha fazla sayıda hastanın (78/102) inotrop desteğine gereksinimi oldu (p 2 triküspid yetmezlik aortik kros klemp grubunda daha sık görüldü (sırasıyla %3’e kıyasla %16; p=0.0023). Takibin birinci yılında rezidüel >2 triküspid yetmezlik aortik kros klemp grubunda 22 hastada (%23) ve atan kalp grubunda sekiz hastada (%8) gözlendi (p=0.0048). Sonuç: Atan kalpte triküspid kapak tamiri ile inotrop desteği daha az ve ameliyat sonrası kalıcı pacemaker implantasyon gereksinimi ve rezidüel triküspid yetmezlik oranı daha düşük olmakla birlikte, her iki tekniğin de ameliyat sonrası klinik sonuçları benzerdir. Bu sonuçlar, eş zamanlı sol taraflı kalp kapak cerrahisinde atan kalpte triküspid kapak tamiri yapılmasını desteklemektedir.

🔖

Cite This Article

ÇAKICI, M., ÖZÇINAR, E., HASDE, A. İ., İNAN, M. B., AKAR, A. R., BARAN, Ç., ERYILMAZ, S., YAZICIOĞLU, L. (2022). Comparison of aortic cross-clamping versus beating heart surgery in tricuspid valve repair. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 26 - Sayı: 4, 519–527. https://ajindex.com/articles/423865

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739-91. McCarthy PM. Evolving Approaches to Tricuspid Valve Surgery: Moving To Europe? J Am Coll Cardiol 2015;65:1939-40.
  2. Rogers JH, Bolling SF. The tricuspid valve: current perspective and evolving management of tricuspid regurgitation. Circulation 2009;119:2718-25.
  3. Chikwe J, Itagaki S, Anyanwu A, Adams DH. Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation, Right Ventricular Function, and Pulmonary Artery Hypertension After Repair of Mitral Valve Prolapse. J Am Coll Cardiol 2015;65:1931-8.
  4. Van Praet KM, Stamm C, Sündermann SH, Meyer A, Unbehaun A, Montagner M, et al. Minimally Invasive Surgical Mitral Valve Repair: State of the Art Review. Interv Cardiol 2018;13:14-9.
  5. Overgaard CB, Dzavík V. Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation 2008;118:1047-56.
  6. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, BarónEsquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.
  7. Schulze C, Conrad N, Schütz A, Egi K, Reichenspurner H, Reichart B, et al. Reduced expression of systemic proinflammatory cytokines after off-pump versus conventional coronary artery bypass grafting. Thorac Cardiovasc Surg 2000;48:364-9.
  8. Matsumoto Y, Watanabe G, Endo M, Sasaki H, Kasashima F, Kosugi I. Efficacy and safety of on-pump beating heart surgery for valvular disease. Ann Thorac Surg 2002;74:678-83.
  9. Romano MA, Haft JW, Pagani FD, Bolling SF. Beating heart surgery via right thoracotomy for reoperative mitral valve surgery: a safe and effective operative alternative. J Thorac Cardiovasc Surg 2012;144:334-9.
  10. Salerno TA, Panos AL, Tian G, Deslauriers R, Calcaterra D, Ricci M. Surgery for cardiac valves and aortic root without cardioplegic arrest (“beating heart”): experience with a new method of myocardial perfusion. J Card Surg 2007;22:459-64.
  11. Salerno TA, Suarez MR, Panos AL, Macedo FI, Alba J, Brown M, et al. Efficacy, feasibility, and pitfalls of transseptal approach in beating-heart mitral valve surgery. J Card Surg 2009;24:495-8.
  12. Ricci M, Macedo FI, Suarez MR, Brown M, Alba J, Salerno TA. Multiple valve surgery wit